This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

What's the market potential of EyeGate Ocular Bandage Gel now that the FDA has agreed to review it via the De Novo 510(k) pathway.

Ticker(s): EYEG

Who's the expert?

An eye doctor who has significant experience performing Photorefractive keratectomy procedures. A familiarity with the concept behind how EyeGate Ocular Bandage could accelerate re-epithelization post PRK

Interview Questions
Q1.

How many PRK procedures do you do per year?

Added By: joe_mccann
Q2.

Currently, how much of an issue are these PRK issues:

  1.  Post-operative pain secondary to the epithelial defects 
  2.  Risk of corneal infection prior to re-epithelization of the large epithelial defect
  3.  Corneal haze formation 
  4.  Decreased contrast sensitivity  
  5.  Slower visual recovery

Added By: joe_mccann
Q3.

Of the items listed above, which do you think the EyeGate Ocular Bandage could address? What is the clinically minimum thresholds needed to make this therapy used with every PRK procedure? To increase the appeal of PRK vs. Lasik?

Added By: joe_mccann
Q4.

How many PRK procedures are done annually and is that number changing meaningfully? 

Added By: joe_mccann

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.